APOBEC3A/B-induced mutagenesis is responsible for 20% of heritable mutations in the TpCpW context

Genome Research

Volumn 27, Issue 2, 2017, Pages 175-184

  Seplyarskiy, Vladimir B ^a,b   Andrianova, Maria A ^a,b,c   Bazykin, Georgii A ^a,b,c,d  

^a INSTITUTE FOR INFORMATION TRANSMISSION PROBLEMS   (Russian Federation)

^b PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

^d SKOLKOVO INSTITUTE OF SCIENCE AND TECHNOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

APOBEC3A PROTEIN; APOBEC3B PROTEIN; PROTEIN; UNCLASSIFIED DRUG; APOBEC3A PROTEIN, HUMAN; CYTIDINE DEAMINASE;

ARTICLE; CONTROLLED STUDY; DEAMINATION; DNA REPLICATION TIMING; GENE CLUSTER; GENE CONVERSION; GENE FREQUENCY; GERMLINE MUTATION; HUMAN; INDUCED MUTATION; MUTAGENESIS; MUTATION RATE; MUTATIONAL LOAD; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; DNA REPLICATION; GENETICS; NEOPLASM; SACCHAROMYCES CEREVISIAE;

CYTIDINE DEAMINASE; DNA REPLICATION; GERM-LINE MUTATION; HUMANS; MUTAGENESIS; MUTATION RATE; NEOPLASMS; PROTEINS; SACCHAROMYCES CEREVISIAE;

EID: 85013020597     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.210336.116     Document Type: Article

References (69)

1. The 1000 Genomes Project Consortium. 2015. Aglobal reference for human genetic variation. Nature 526: 68-74.
2. Aggarwala V, Voight BF. 2016. An expanded sequence context model broadly explains variability in polymorphism levels across the human genome. Nat Genet 48: 349-355.
3. Akre MK, Starrett GJ, Quist JS, Temiz NA, Carpenter MA, Tutt ANJ, Grigoriadis A, Harris RS. 2016. Mutation processes in 293-based clones overexpressing the DNA cytosine deaminase APOBEC3B. PLoS One 11: e0155391.
4. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SAJR, Behjati S, Biankin AV, Bignell GR, Bolli N, Borg A, Børresen-Dale A-L, et al. 2013. Signatures of mutational processes in human cancer. Nature 500: 415-421.
5. Andrianova M, Bazykin GA, Nikolaev S, Seplyarskiy V. 2016. Human mismatch repair system corrects errors produced during lagging strand replication more effectively. bioRxiv 45278. doi: https://doi.org/10.1101/045278.
6. Arbeithuber B, Betancourt AJ, Ebner T, Tiemann-Boege I. 2015. Crossovers are associated with mutation and biased gene conversion at recombination hotspots. Proc Natl Acad Sci 112: 2109-2114.
7. Baker A, Audit B, Chen C-L, Moindrot B, Leleu A, Guilbaud G, Rappailles A, Vaillant C, Goldar A, Mongelard F, et al. 2012. Replication fork polarity gradients revealed by megabase-sized U-shaped replication timing domains in human cell lines. PLoS Comput Biol 8: e1002443.
8. Bhagwat AS, Hao W, Townes JP, Lee H, Tang H, Foster PL. 2016. Strand-biased cytosine deaminationat the replication fork causes cytosine to thy-mine mutations in Escherichia coli. Proc Natl Acad Sci 113: 2176-2181.
9. Burns MB, Lackey L, Carpenter MA, Rathore A, Land AM, Leonard B, Refsland EW, Kotandeniya D, Tretyakova N, Nikas JB, et al. 2013a. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494: 366-370.
10. Burns MB, Temiz NA, Harris RS. 2013b. Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat Genet 45: 977-983.
11. Chan K, Resnick MA, Gordenin DA. 2013. The choice of nucleotide inserted opposite abasic sites formed within chromosomal DNA reveals the polymerase activities participating in translesion DNA synthesis. DNA Repair 12: 878-889.
12. Chan K, Roberts SA, Klimczak LJ, Sterling JF, Saini N, Malc EP, Kim J, Kwiatkowski DJ, Fargo DC, Mieczkowski PA, et al. 2015. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers. Nat Genet 47: 1067-1072.
13. Chen C-L, Duquenne L, Audit B, Guilbaud G, Rappailles A, Baker A, Huvet M, d'Aubenton-Carafa Y, Hyrien O, Arneodo A, et al. 2011. Replication-associated mutational asymmetry in the human genome. Mol Biol Evol 28: 2327-2337.
14. Chen J, Miller BF, Furano AV. 2014. Repair of naturally occurring mismatches can induce mutations in flanking DNA. eLife 3: e02001.
15. Diaz M, Watson NB, Turkington G, Verkoczy LK, Klinman NR, McGregor WG. 2003. Decreased frequency and highly aberrant spectrum of ultraviolet-induced mutations in the hprt gene of mouse fibroblasts expressing antisense RNA to DNA polymerase ζ. Mol Cancer Res 1: 836-847.
16. Farkash-Amar S, Lipson D, Polten A, Goren A, Helmstetter C, Yakhini Z, Simon I. 2008. Global organization of replication time zones of the mouse genome. Genome Res 18: 1562-1570.
17. Francioli LC, Polak PP, Koren A, Menelaou A, Chun S, Renkens I, Genome of the Netherlands Consortium, van Duijn CM, Swertz M, Wijmenga C, et al. 2015. Genome-wide patterns and properties of de novo mutations in humans. Nat Genet 47: 822-826.
18. Goldmann JM, Wong WSW, Pinelli M, Farrah T, Bodian D, Stittrich AB, Glusman G, Vissers LELM, Hoischen A, Roach JC, et al. 2016. Parent-of-origin-specific signatures of de novo mutations. Nat Genet 48: 935-939.
19. Green P, Ewing B, Miller W, Thomas PJ, NISC Comparative Sequencing Program, Green ED. 2003. Transcription-associated mutational asymmetry in mammalian evolution. Nat Genet 33: 514-517.
20. Green AM, Landry S, Budagyan K, Avgousti DC, Shalhout S, Bhagwat AS, Weitzman MD. 2016. APOBEC3A damages the cellular genome during DNA replication. Cell Cycle 15: 998-1008.
21. Guilbaud G, Rappailles A, Baker A, Chen C-L, Arneodo A, Goldar A, d'Aubenton-Carafa Y, Thermes C, Audit B, Hyrien O. 2011. Evidence for sequential and increasing activation of replication origins along replication timing gradients in the human genome. PLoS Comput Biol 7: e1002322.
22. Haradhvala NJ, Polak P, Stojanov P, Covington KR, Shinbrot E, Hess JM, Rheinbay E, Kim J, Maruvka YE, Braunstein LZ, et al. 2016. Mutational strand asymmetries in cancer genomes reveal mechanisms of DNA damage and repair. Cell 164: 538-549.
23. Harris K, Nielsen R. 2014. Error-prone polymerase activity causes multinu-cleotide mutations in humans. Genome Res 24: 1445-1454.
24. Helleday T, Eshtad S, Nik-Zainal S. 2014. Mechanisms underlying mutational signatures in human cancers. Nat Rev Genet 15: 585-598.
25. Hoadley KA, Yau C, Wolf DM, Cherniack AD, Tamborero D, Ng S, Leiserson MDM, Niu B, McLellan MD, Uzunangelov V, et al. 2014. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 158: 929-944.
26. Hodgkinson A, Ladoukakis E, Eyre-Walker A. 2009. Cryptic variation in the human mutation rate. PLoS Biol 7: e1000027.
27. Hoopes JI, Cortez LM, Mertz TM, Malc EP, Mieczkowski PA, Roberts SA. 2016. APOBEC3A and APOBEC3B preferentially deaminate the lagging strand template during DNA replication. Cell Rep 14: 1273-1282.
28. Johnson PLF, Hellmann I. 2011. Mutation rate distribution inferred from coincident SNPs and coincident substitutions. Genome Biol Evol 3: 842-850.
29. Kim E-Y, Lorenzo-Redondo R, Little SJ, Chung Y-S, Phalora PK, Maljkovic Berry I, Archer J, Penugonda S, Fischer W, Richman DD, et al. 2014. Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection. PLoS Pathog 10: e1004281.
30. Knisbacher BA, Levanon EY. 2016. DNA editing of LTR retrotransposons reveals the impact of APOBECs on vertebrate genomes. Mol Biol Evol 33: 554-567.
31. Kochenova OV, Daee DL, Mertz TM, Shcherbakova PV. 2015. DNA polymerase ζ-dependent lesion bypass in Saccharomyces cerevisiae is accompanied by error-prone copying of long stretches of adjacent DNA. PLoS Genet 11: e1005110.
32. Kong A, Frigge ML, Masson G, Besenbacher S, Sulem P, Magnusson G, Gudjonsson SA, Sigurdsson A, Jonasdottir A, Jonasdottir A, et al. 2012. Rate of de novo mutations and the importance of father's age to disease risk. Nature 488: 471-475.
33. Koren A, Handsaker RE, Kamitaki N, Karlic R, Ghosh S, Polak P, Eggan K, McCarroll SA. 2014. Genetic variation in human DNA replication timing. Cell 159: 1015-1026.
34. Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH, Roberts SA, et al. 2013. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499: 214-218.
35. Lujan SA, Williams JS, Pursell ZF, Abdulovic-Cui AA, Clark AB, Nick McElhinny SA, Kunkel TA. 2012. Mismatch repair balances leading and lagging strand DNA replication fidelity. PLoS Genet 8: e1003016.
36. Lujan SA, Clausen AR, Clark AB, MacAlpine HK, MacAlpine DM, Malc EP, Mieczkowski PA, Burkholder AB, Fargo DC, Gordenin DA, et al. 2014. Heterogeneous polymerase fidelity and mismatch repair bias genome variation and composition. Genome Res 24: 1751-1764.
37. Martincorena I, Campbell PJ. 2015. Somatic mutation in cancer and normal cells. Science 349: 1483-1489.
38. Mathieson I, McVean G. 2014. Demography and the age of rare variants. PLoS Genet 10: e1004528.
39. Mathieson I, Reich DE. 2016. Variation in mutation rates among human populations. bioRxiv 63578. doi: https://doi.org/10.1101/063578.
40. Montgomery SB, Goode DL, Kvikstad E, Albers CA, Zhang ZD, Mu XJ, Ananda G, Howie B, Karczewski KJ, Smith KS, et al. 2013. The origin, evolution, and functional impact of short insertion-deletion variants identified in 179 human genomes. Genome Res 23: 749-761.
41. Morganella S, Alexandrov LB, Glodzik D, Zou X, Davies H, Staaf J, Sieuwerts AM, Brinkman AB, Martin S, Ramakrishna M, et al. 2016. The topography of mutational processes in breast cancer genomes. Nat Commun 7: 11383.
42. Mu XJ, Lu ZJ, Kong Y, Lam HYK, Gerstein MB. 2011. Analysis of genomic variation in non-coding elements using population-scale sequencing data from the 1000 Genomes Project. Nucleic Acids Res 39: 7058-7076.
43. Mugal CF, von Grünberg H-H, Peifer M. 2009. Transcription-induced mutational strand bias and its effect on substitution rates in human genes. Mol Biol Evol 26: 131-142.
44. Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K, Jones D, Hinton J, Marshall J, Stebbings LA, et al. 2012. Mutational processes molding the genomes of 21 breast cancers. Cell 149: 979-993.
45. Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, Martincorena I, Alexandrov LB, Martin S, Wedge DC, et al. 2016. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534: 47-54.
46. Nordentoft I, Lamy P, Birkenkamp-Demtröder K, Shumansky K, Vang S, Hornshøj H, Juul M, Villesen P, Hedegaard J, Roth A, et al. 2014. Mutational context and diverse clonal development in early and late bladder cancer. Cell Rep 7: 1649-1663.
47. Pfeifer GP 2006. Mutagenesis at methylated CpG sequences. Curr Top Microbiol Immunol 301: 259-281.
48. Pinto Y, Gabay O, Arbiza L, Sams AJ, Keinan A, Levanon EY. 2016. Clustered mutations in hominid genome evolution are consistent with APOBEC3G enzymatic activity. Genome Res 26: 579-587.
49. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD, Varela I, Lin M-L, Ordóñez GR, Bignell GR, et al. 2010. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463: 191-196.
50. Polak P, Arndt PF. 2008. Transcription induces strand-specific mutations at the 5' end of human genes. Genome Res 18: 1216-1223.
51. Pratto F, Brick K, Khil P, Smagulova F, Petukhova GV, Camerini-Otero RD. 2014. DNA recombination. Recombination initiation maps of individual human genomes. Science 346: 1256442.
52. Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Al Turki S, Dominiczak A, Morris A, Porteous D, Smith B, et al. 2016. Timing, rates and spectra of human germline mutation. Nat Genet 48: 126-133.
53. Roberts SA, Lawrence MS, Klimczak LJ, Grimm SA, Fargo D, Stojanov P, Kiezun A, Kryukov GV, Carter SL, Saksena G, et al. 2013. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet 45: 970-976.
54. Rouhani FJ, Nik-Zainal S, Wuster A, Li Y, Conte N, Koike-Yusa H, Kumasaka N, Vallier L, Yusa K, Bradley A. 2016. Mutational history of a human cell lineage from somatic to induced pluripotent stem cells. PLoS Genet 12: e1005932.
55. Saraconi G, Severi F, Sala C, Mattiuz G, Conticello SG. 2014. The RNA editing enzyme APOBEC1 induces somatic mutations and a compatible mutational signature is present in esophageal adenocarcinomas. Genome Biol 15: 417.
56. Schrider DR, Hourmozdi JN, Hahn MW. 2011. Pervasive multinucleotide mutational events in eukaryotes. Curr Biol 21: 1051-1054.
57. Seplyarskiy VB, Kharchenko P, Kondrashov AS, Bazykin GA. 2012. Heterogeneity of the transition/transversion ratio in Drosophila and Hominidae genomes. Mol Biol Evol 29: 1943-1955.
58. Seplyarskiy VB, Bazykin GA, Soldatov RA. 2015. Polymerase ζ activity is linked to replication timing in humans: evidence from mutational signatures. Mol Biol Evol 32: 3158-3172.
59. Seplyarskiy VB, Soldatov RA, Popadin KY, Antonarakis SE, Bazykin GA, Nikolaev SI. 2016. APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication. Genome Res 26: 174-182.
60. Shendure J, Akey JM. 2015. The origins, determinants, and consequences of human mutations. Science 349: 1478-1483.
61. Skourti-Stathaki K, Proudfoot NJ. 2014. A double-edged sword: R loops as threats to genome integrity and powerful regulators of gene expression. Genes Dev 28: 1384-1396.
62. Starrett GJ, Luengas EM, McCann JL, Ebrahimi D, Temiz NA, Love RP, Feng Y, Adolph MB, Chelico L, Law EK, et al. 2016. The DNA cytosine deaminase APOBEC3H haplotype I likely contributes to breast and lung cancer mutagenesis. Nat Commun 7: 12918.
63. Taylor BJ, Nik-Zainal S, Wu YL, Stebbings LA, Raine K, Campbell PJ, Rada C, Stratton MR, Neuberger MS. 2013. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. eLife 2: e00534.
64. Terekhanova NV, Bazykin GA, Neverov A, Kondrashov AS, Seplyarskiy VB. 2013. Prevalence of multinucleotide replacements in evolution of primates and Drosophila. Mol Biol Evol 30: 1315-1325.
65. Terekhanova NV, Seplyarskiy V, Soldatov RA, Bazykin GA. 2016. Evolution of local mutation rate and its determinants. bioRxiv 54825. doi: https://doi.org/10.1101/054825.
66. Wong WSW, Solomon BD, Bodian DL, Kothiyal P, Eley G, Huddleston KC, Baker R, Thach DC, Iyer RK, Vockley JG, et al. 2016. New observations on maternal age effect on germline de novo mutations. Nat Commun 7: 10486.
67. Yang S, Wang L, Huang J, Zhang X, Yuan Y, Chen J-Q, Hurst LD, Tian D. 2015. Parent-progeny sequencing indicates higher mutation rates in heterozygotes. Nature 523: 463-467.
68. Yuen RK, Merico D, Cao H, Pellecchia G, Alipanahi B, Thiruvahindrapuram B, Tong X, Sun Y, Cao D, Zhang T, et al. 2016. Genome-wide characteristics of de novo mutations in autism. NPJ Genom Med 1: 16027.
69. Zhu W, Cooper DN, Zhao Q, Wang Y, Liu R, Li Q, Férec C, Wang Y, Chen JM. 2015. Concurrent nucleotide substitution mutations in the human genome are characterized by a significantly decreased transition/transversion ratio. Hum Mutat 36: 333-341.